179.98  -0.41 (-0.23%)		08-29 16:00
Open: 180.93 High: 180.93 Volume: 806,054		Pre. Close: 180.39 Low: 179.24 Market Cap: 36,150(M)

Short term
Mid term
Targets	6-month :		1-year :
Resists	First :		Second :
Pivot price
Supports	First :		Second :
MAs	MA(5) :		MA(20) :
	MA(100) :		MA(250) :
MACD	MACD :		Signal :
%K %D	K(14,3) :		D(3) :
RSI	RSI(14):
52-week	High :		Low :

If tomorrow:	Open lower	Open higher
High:	-	-
Low:	-	-
Close:	-	-

AmerisourceBergen Corporation (ABC) operates as a prominent global distributor and procurer of pharmaceutical products. Its core business is structured around two main segments. The Pharmaceutical Distribution division is responsible for the extensive supply of both brand-name and generic medicines, alongside over-the-counter health items, and equipment for home healthcare. This segment extends its services to a wide array of healthcare entities, including acute care hospitals, integrated health systems, independent and chain retail pharmacies, mail-order drug providers, medical clinics, and facilities offering long-term care or alternative site pharmacy services. Beyond product distribution, it offers comprehensive pharmacy management and staffing solutions, consulting expertise, and specialized supply chain software tailored for both retail and institutional healthcare settings. Furthermore, ABC provides bespoke packaging services. This division also manages the distribution of vital plasma and blood products, various injectable pharmaceuticals, vaccines, and other specialty medications. It furnishes support services primarily to physicians specializing in areas like oncology, as well as to hospitals and dialysis centers, while also delivering critical data analytics, outcomes research, and supplementary services to biotechnology and pharmaceutical manufacturers. The Other segment encompasses a range of integrated services for manufacturers, spanning clinical trial assistance, post-approval support, and commercialization strategies for new products. It also manages specialized transportation and logistics crucial for the biopharmaceutical sector. Additionally, this segment supplies pharmaceuticals, vaccines, parasiticides, diagnostic tools, and micro feed ingredients to both companion animal and production animal markets. It further aids manufacturers by providing sales force services aimed at generating demand. AmerisourceBergen Corporation was established in 2001 and maintains its headquarters in Conshohocken, Pennsylvania.

Mon, 23 Mar 2026
Kathleen W. Hyle - X-energy

Wed, 30 Aug 2023
AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care - Business Wire

Thu, 03 Aug 2023
Walgreens sells $1.85 billion of AmerisourceBergen shares, further cutting stake - Reuters

Tue, 24 Jan 2023
AmerisourceBergen is changing its name - The Business Journals

Thu, 05 Jan 2023
Do Options Traders Know Something About AmerisourceBergen (ABC) Stock We Don't? - Yahoo Finance

Thu, 23 Jun 2022
US Bioservices Acquired by CVS - Anton Health

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Distribution
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	(%)
Held by Institutions	(%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS
EPS Est Next Qtrly
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin	%
Operating Margin	%
Return on Assets (ttm)	%
Return on Equity (ttm)	%
Qtrly Rev. Growth	%
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth	%
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Dividend
Forward Dividend
Dividend Yield	0%
Dividend Pay Date
Ex-Dividend Date